S
AZN icon

Surevest’s AstraZeneca AZN Stock Holding History

Surevest’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$18K Hold
168
– – ﹤0.01% 249
2022
Q2 		$22K Hold
168
– – 0.01% 253
2022
Q1 		$22K Hold
168
– – 0.01% 234
2021
Q4 		$20K Buy
+168
New +$19.8K ﹤0.01% 247

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Surevest's AZN Position: Q3 2022 in Review

Surevest held its AstraZeneca (AZN) position steady in Q3 2022 at 168 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Surevest first reported a position in AZN in Q4 2021 and has held it in 4 quarters since. The position peaked at $22K in Q2 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • Surevest held 168 shares of AstraZeneca worth $18K as of Q3 2022.
  • Surevest left its AstraZeneca share count unchanged in Q3 2022.
  • AstraZeneca made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #249 holding.
  • Surevest first reported a position in AstraZeneca in Q4 2021 and has held it in 4 quarters since.
  • Surevest's AstraZeneca position peaked at $22K in Q2 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.